Seasonal Influenza Vaccines Therapeutics Market size is estimated to be USD 5.6 Billion in 2024 and is expected to reach USD 9.8 Billion by 2033 at a CAGR of 6.5% from 2026 to 2033.
South Korea's Seasonal Influenza Vaccines Therapeutics Market: Industry Demands and Strategic Shifts
South Korea's Seasonal Influenza Vaccines Therapeutics Market is undergoing significant transformation, driven by demographic shifts, evolving public health policies, and technological advancements. The nation's aging population, with over 80% vaccination coverage among those aged 65 and above, underscores the critical need for effective immunization strategies.
Key developments include:
Adoption of Advanced Vaccines: The introduction of MF59-adjuvanted quadrivalent influenza vaccines (aQIV) has shown promising results, potentially reducing influenza cases by 9.52% and preventing approximately 145 deaths annually among the elderly.
Expansion of Free Vaccination Programs: The National Immunization Program (NIP) has progressively extended free vaccinations to children under 13, pregnant women, and temporarily to other vulnerable groups during health crises, reflecting a commitment to broadening protective measures.
Domestic Vaccine Production: Post-2009, South Korea has achieved approximately 70% self-sufficiency in vaccine production, enhancing supply chain resilience and reducing dependency on imports.
Industry stakeholders are responding to these shifts by investing in research and development of high-dose and adjuvanted vaccines, optimizing distribution channels, and engaging in public-private partnerships to enhance vaccine accessibility and coverage.
Despite these advancements, challenges persist, including ensuring vaccine effectiveness amidst viral mutations and addressing vaccine hesitancy. Continuous monitoring and adaptive strategies are essential to maintain and improve public health outcomes.
In summary, South Korea's proactive approach in evolving its Seasonal Influenza Vaccines Therapeutics Market demonstrates a robust framework for managing influenza risks, with ongoing efforts to align industry capabilities with public health needs.
Get an In-Depth Research Analysis of the South Korea Seasonal Influenza Vaccines Therapeutics Market Size And Forecast [2025-2032]
GSK
Novartis
CSL
MedImmune
Sanofi-Pasteur
Solvay
Sinovac Biotech
Hualun Biologicals
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Seasonal Influenza Vaccines Therapeutics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Seasonal Influenza Vaccines Therapeutics Market
Inactivated Influenza Vaccines (IIV)
Live Attenuated Influenza Vaccines (LAIV)
Recombinant Influenza Vaccines (RIV)
Quadrivalent Influenza Vaccines
Trivalent Influenza Vaccines
Children (6 months to 18 years)
Adults (19 to 64 years)
Seniors (65 years and older)
Publicly Funded Vaccines
Privately Funded Vaccines
Government-Sponsored Vaccines
Intramuscular Vaccines
Nasal Spray Vaccines
Intradermal Vaccines
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Healthcare Providers
Public Health Organizations
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Seasonal Influenza Vaccines Therapeutics Market Research Analysis
1. Introduction of the South Korea Seasonal Influenza Vaccines Therapeutics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Seasonal Influenza Vaccines Therapeutics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Seasonal Influenza Vaccines Therapeutics Market, By Type
6. South Korea Seasonal Influenza Vaccines Therapeutics Market, By Application
7. South Korea Seasonal Influenza Vaccines Therapeutics Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Seasonal Influenza Vaccines Therapeutics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/